List of insiders holdings for HALOZYME THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | KIRK RANDAL J 10% Owner |
2019-11-05 16:53:10 | 7,046,385 0 |
7,046,385 | Form 13D |
2 | Frost Gregory Ian CEO, President |
2013-12-11 19:33:00 | 3,676,911 0 |
3,676,911 | Form 4 |
3 | LECHNER IRA M Director |
2004-03-19 14:12:33 | 100,000 1,052,329 |
1,152,329 | Form 3 |
4 | MERCALDO EDWARD L Director |
2004-03-19 14:13:19 | 126,944 692,994 |
819,938 | Form 3 |
5 | Torley Helen PRESIDENT AND CEO |
2025-02-24 17:01:43 | 801,027 0 |
801,027 | Form 4 |
6 | Wilson Mark S Vice President |
2005-02-11 15:46:01 | 544,240 0 |
544,240 | Form 3/A |
7 | Rynard Carolyn Vice President |
2005-02-11 15:55:34 | 494,240 0 |
494,240 | Form 3/A |
8 | RAMSAY DAVID A VP and Chief Financial Officer |
2015-02-06 19:52:31 | 458,582 0 |
458,582 | Form 4 |
9 | FALBERG KATHRYN E Director |
2016-05-06 16:47:56 | 358,253 0 |
358,253 | Form 4 |
10 | Engler Robert Director |
2014-08-18 16:59:47 | 273,176 0 |
273,176 | Form 4 |
11 | Leff Jonathan A VP, Chief Medical Officer |
2009-08-07 20:20:32 | 200,000 0 |
200,000 | Form 4 |
12 | Armour Alison A. SVP, Research & Development |
2019-06-04 16:44:05 | 195,278 0 |
195,278 | Form 4 |
13 | MATSUI CONNIE Director |
2024-12-03 16:05:40 | 183,035 0 |
183,035 | Form 4 |
14 | PATTON JOHN STUART Director |
2014-08-21 17:07:42 | 179,876 0 |
179,876 | Form 4 |
15 | Kelley Kenneth J Director |
2021-04-14 16:19:55 | 179,833 0 |
179,833 | Form 4 |
16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2025-02-27 18:32:38 | 173,756 0 |
173,756 | Form 4 |
17 | Yocum Richard C VP-Clinical Development |
2008-02-08 17:50:38 | 150,943 0 |
150,943 | Form 4 |
18 | Stelzer Laurie SVP, Chief Financial Officer |
2020-02-24 20:03:57 | 127,559 10,000 |
137,559 | Form 4 |
19 | Hooper Matthew Vice Pres & General Counsel |
2007-11-13 16:35:47 | 125,000 0 |
125,000 | Form 4 |
20 | Lim Jonathan E Chief Executive Officer |
2010-02-08 17:06:43 | 120,000 0 |
120,000 | Form 4 |
21 | Countouriotis Athena SVP and Chief Medical Officer |
2017-02-24 16:06:20 | 118,493 0 |
118,493 | Form 4 |
22 | Gergen Mark J SVP, Chief Operating Officer |
2017-02-24 16:05:43 | 118,493 0 |
118,493 | Form 4 |
23 | GUSTAFSON KURT A Vice President and CFO |
2013-02-06 18:58:12 | 99,200 0 |
99,200 | Form 4 |
24 | Shaffer James P VP & Chief Commercial Officer |
2014-02-10 17:57:12 | 81,500 0 |
81,500 | Form 4 |
25 | LIU JEAN I VP & General Counsel |
2014-02-10 17:55:14 | 81,500 0 |
81,500 | Form 4 |
26 | BIZZARI JEAN-PIERRE Director |
2023-05-09 18:09:24 | 78,186 0 |
78,186 | Form 4 |
27 | Hickey Benjamin SVP, Chief Commerical Officer |
2019-10-01 19:10:12 | 73,873 0 |
73,873 | Form 4 |
28 | Posard Matthew L. Director |
2024-08-14 16:57:27 | 69,874 0 |
69,874 | Form 4 |
29 | LEONHARDT HARRY J SVP, GC |
2019-04-15 16:08:01 | 66,373 0 |
66,373 | Form 4 |
30 | Connaughton Bernadette Director |
2024-04-29 17:51:24 | 55,591 0 |
55,591 | Form 4 |
31 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2025-02-24 17:04:21 | 51,963 0 |
51,963 | Form 4 |
32 | Thornton Steven T Director |
2008-05-09 18:26:18 | 50,000 0 |
50,000 | Form 4 |
33 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
2025-02-24 17:07:14 | 49,522 0 |
49,522 | Form 4 |
34 | Sun Elaine D SVP, Chief Financial Officer |
2021-04-01 19:43:33 | 44,618 0 |
44,618 | Form 4 |
35 | Chondros Dimitrios SVP, Chief Medical Officer |
2019-08-05 20:11:39 | 38,584 0 |
38,584 | Form 4 |
36 | Henderson Jeffrey William Director |
2025-04-01 18:32:16 | 33,108 0 |
33,108 | Form 4 |
37 | Miyashita Akiko Moni Director |
2024-04-29 18:08:11 | 29,576 0 |
29,576 | Form 4 |
38 | LITTLE ROBERT J VP, Chief Commercial Officer |
2010-02-08 17:52:41 | 28,000 0 |
28,000 | Form 4 |
39 | Matsuda Masaru SVP, General Counsel |
2021-09-07 17:42:24 | 26,932 0 |
26,932 | Form 4 |
40 | Duncan Barbara Gayle Director |
2024-04-29 17:54:20 | 24,558 0 |
24,558 | Form 4 |
41 | DAY MELLISSA former officer, director Director |
2004-03-12 13:24:02 | 22,374 0 |
22,374 | Form 4 |
42 | Daly James M Director |
2023-08-15 16:04:28 | 20,503 0 |
20,503 | Form 4 |
43 | Fallon William J VP, Manufacturing & Operations |
2011-05-11 19:44:04 | 19,000 0 |
19,000 | Form 4 |
44 | Krishnan Mahesh Director |
2024-04-29 18:01:02 | 15,305 0 |
15,305 | Form 4 |
45 | KEELER MITCH former off., dir., 10% owner |
2004-03-12 13:52:53 | 15,000 0 |
15,000 | Form 13G |
46 | Shepard H. Michael VP, Chief Scientific Officer |
2013-09-11 18:12:07 | 13,198 0 |
13,198 | Form 4 |
47 | Kennard Don A Vice President, Regulatory Aff |
2007-05-23 16:16:59 | 0 0 |
0 | Form 4 |